$2 million to study role-switching cells in heart failure
The National Institutes of Health has awarded more than
$2 million to a team of scientists from Washington University in St.
Louis and InvivoSciences, a biotechnology startup with WUSTL roots, to
construct artificial tissue models that will allow the rapid testing of
new drugs for heart failure.